Kivo Health Announces Positive Results in Peer Reviewed Study
We're thrilled to share positive results from the latest peer-reviewed study on Kivo’s AI-powered virtual pulmonary rehabilitation (PR) intervention for COPD patients.
Our care delivery model demonstrates both safety and efficacy across all patient groups – including those on supplemental oxygen and those not on supplemental oxygen.
Key Highlights:
- High Engagement: An impressive 88% median attendance rate, showing that our virtual approach is both feasible and engaging.
- Safety: Zero major adverse events, with only 1% of participants experiencing minor adverse events underscoring the safety of our care model.
- Clinical Efficacy: Participants showed statistically significant improvements in breathlessness, depression, and exercise capacity, with results meeting or surpassing clinically important benchmarks.
- Broad applicability: No significant difference in outcomes between patients on supplemental oxygen and those not.
This is the first study to directly compare patients on supplemental oxygen and those not on supplemental oxygen in a virtual setting, marking a significant step forward in personalized, scalable, and accessible COPD care.
We commend the outstanding work by physician-scientists at UCLA in designing and publishing this independent study. Hector Filizola, MD; Anirudh Kumar, MD, MPH; Russell Buhr, MD, PhD, FACP, ATSF; Kristin Schwab Jensen, MD
––––––––